Navigation Links
NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
Date:7/29/2009

SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Patrick Williams, Vice President of Finance and Investor Relations, is scheduled to present at the BMO Capital Markets Focus on Healthcare Conference at The Millennium Broadway Hotel in New York, New York, on Wednesday, August 5, 2009, at 11:15 a.m. ET.

A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.nuvasive.com. After the live webcast, the presentation will remain available on the website for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused primarily on the $4.6 billion U.S. spine implant market. Additionally, the Company has expanded into the $1.5 billion global biologics market, the $1.5 billion international market, and is developing products for the emerging motion preservation market.

NuVasive's principal product offering is based on its Maximum Access Surgery, or MAS(R) platform. The MAS platform combines four categories of products that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: NeuroVision(R), a proprietary software-driven nerve avoidance system; MaXcess(R), a unique split-blade retractor system; a wide variety of specialized implants; and several biologic fusion enhancers. MAS significantly reduces surgery time and returns patients to activities of
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference
2. NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results
3. NuVasive Licenses Its Insert and Rotate Technology
4. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
5. NuVasive to Present at BIOCOM Investor Conference 2007
6. NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results
7. NuVasive to Offer $200 Million Convertible Senior Notes Due 2013
8. NuVasive Prices $200 Million Convertible Senior Notes Due 2013
9. NuVasive Reports First Quarter 2008 Financial Results
10. NuVasive Acquires First Stem Cell Bone Graft Substitute
11. NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014 Financing for Development ... innovative financing for international development, has announced the ... includes six Directors: Mr. John Skibiak of the ... the Millennium Challenge Corporation, Mr. Pape Gaye of ... Advisors, Mr. Aron Betru of Financing for Development, ...
(Date:11/18/2014)... Hills, CA (PRWEB) November 18, 2014 ... and workflow solutions, announced today their Gold sponsorship of ... November 19th through Friday, November 21st at the Fargo, ... event offering targeted Microsoft Dynamics GP training sessions and ... the Microsoft campus is an excellent way for users ...
(Date:11/18/2014)... Sorrel Sky Gallery welcomes jewelry ... selection of her beautiful, one-of-a-kind pieces. Just in time for ... the gallery, Friday, December 5 from 5 – 7:30 p.m. ... Showers artistic creations began at her grandmother’s kitchen table at ... her designs. She studied at the Gemological Institute of America ...
(Date:11/18/2014)... Tara Haelle HealthDay Reporter ... who experience a severe abusive head trauma before the age ... a new study. In addition, among those who ... half, the study found. Abusive head trauma includes shaken ... and suffers head injuries, according to background information in the ...
(Date:11/18/2014)... Dennis Thompson HealthDay ... Otherwise healthy people on the verge of burning out are ... Those suffering from so-called vital exhaustion -- a toxic ... percent increased risk of developing heart disease, researchers report. ... of stress. And I think, when that stress is left ...
Breaking Medicine News(10 mins):Health News:Financing for Development Corp. (F4D) Announces Board of Directors 2Health News:Financing for Development Corp. (F4D) Announces Board of Directors 3Health News:Financing for Development Corp. (F4D) Announces Board of Directors 4Health News:Altec Joins the 2014 Great Plains User Conference (GPUC) as a Gold Sponsor, Demonstrating the Capabilities of Certified for Microsoft Dynamics Product doc-link 2Health News:Altec Joins the 2014 Great Plains User Conference (GPUC) as a Gold Sponsor, Demonstrating the Capabilities of Certified for Microsoft Dynamics Product doc-link 3Health News:Elizabeth Showers Trunk Show & Personal Appearance Hosted by Sorrel Sky Gallery 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3
... India is closely watching the ‘Avian Flu’ that is ... formed a task force to tackle this emergency. ... and includes secretaries of health, environment, animal husbandry and ... guidelines on how to tackle the problem if it ...
... not be the only factor-probing adolescents to commit suicide.// ... for other mental health problems to prevent youth suicide. ... and distribution of mental disorders in 894 cases of ... the results of the study revealed a majority of ...
... comprises a large, heterogeneous group of rare pulmonary ... and abnormal gas exchange with considerable mortality and ... differential diagnosis includes more than 100 conditions in ... Texas and Colorado conducted a descriptive, observational study ...
... Impotence drug such as Viagra use is linked to development ... with// vision disorders have used Viagra medicines. It is found ... found to cause risk of blindness. Men most at risk ... have diabetes, heart disease, high blood pressure and high cholesterol, ...
... the first time the AID statistics from the newly formed ... cases in the state. ,Uttaranchal is a state ... lower Himalayan area with famous Hindu shrines such as Badrinath, ... the state mostly by infected drivers who are coming from ...
... disorder of impaired insulin secretion and insulin resistance, ... individuals and lifestyle management can help control diabetes; ... achieve glycemic control, a stepwise treatment approach has ... diet and exercise, and to minimize the risk ...
Cached Medicine News:Health News:Multi targeted approach required for suicide prevention in adolescents 2Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2Health News:Impotence drug such as Viagra may cause Vision Loss 2Health News:Glimepiride in the medical management of Type 2 diabetes 2
(Date:11/18/2014)... November 18, 2014 Investor-Edge has initiated ... EXEL ), Geron Corporation (NASDAQ: GERN ), Tekmira ... (NASDAQ: GALE ), and XOMA Corporation (NASDAQ: ... be accessed at: http://investor-edge.com/register . The US ... note as the Dow Jones Industrial Average finished at 17,647.75, ...
(Date:11/18/2014)... , Nov. 18, 2014 Pressure BioSciences, ... announced the installation of its first two Barozyme ... subsequent potential sale. One system was placed in ... of Georgetown University while the other was placed ... In both settings, the Company believes the new ...
(Date:11/18/2014)... MUMBAI , November 18, 2014 ... thorough knowledge of the overall new requirements of application ... China but also provides the guidance ... approval for your products entry into the Chinese medical ... Chinese medical device market is one of segment market ...
Breaking Medicine Technology:Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5Pressure BioSciences Ships First Two Barozyme HT48 Systems 2Pressure BioSciences Ships First Two Barozyme HT48 Systems 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 4Pressure BioSciences Ships First Two Barozyme HT48 Systems 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 2Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 3Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 4Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 6Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 7Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 8
... N.J., May 19 Ikaria Holdings, Inc., a ... it,has completed dosing of its Phase 1a trial ... The study was a Phase 1, randomized, ... a single bolus injection of IK-1001,in healthy volunteers ...
... IPSOGEN SA (Marseille and New,Haven), a cancer profiler ... breast cancers, announced today that researchers from,the University of ... the results of two studies on the Genomic Grade ... from May 30 to June 3, 2008. The data,indicate ...
Cached Medicine Technology:Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 2Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 2Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 4
... end transcription services. Zodiac offers two ... either submitted over the phone via ... 24 hours a day, 7 days ... recorded on a digital handheld recorder ...
... Achieve high-speed productivity in the lab ... system, dedicated for pre- and post-analytical sorting ... HSS selectively decaps and then sorts primary ... to save time, labor, and eliminate ...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
Similar to Model 530, but just 37 inches long and with only one drape....
Medicine Products: